HUMAN NEUROLOGICAL CANCER-CELLS EXPRESS INTERLEUKIN-4 (IL-4) RECEPTORS WHICH ARE TARGETS FOR THE TOXIC EFFECTS OF IL4-PSEUDOMONAS EXOTOXIN CHIMERIC PROTEIN
Rk. Puri et al., HUMAN NEUROLOGICAL CANCER-CELLS EXPRESS INTERLEUKIN-4 (IL-4) RECEPTORS WHICH ARE TARGETS FOR THE TOXIC EFFECTS OF IL4-PSEUDOMONAS EXOTOXIN CHIMERIC PROTEIN, International journal of cancer, 58(4), 1994, pp. 574-581
Glioblastoma, glioma or neuroblastoma cells were examined for the expr
ession of IL-4 receptors (IL-4R) by now cytometric analysis and I-125-
IL-4 binding. These cancer cell lines expressed IL-4R which were of hi
gh affinity (K-D = 700 x 10(-12) M) on glioblastoma cells. To investig
ate the function of these receptors and to target potent cytotoxic ant
itumor agents to human neurological cancers, we utilized IL4-PE4E, whi
ch is composed of IL-4 and mutant Pseudomonas exotoxin (IL4-PE4E). Thi
s chimeric molecule was cytotoxic toward human glioblastoma, neuroblas
toma and glioma tumor cells in a dose-dependent manner. The cytotoxici
ty of IL4-PE4E was specific, since it was neutralized by excess IL-4,
and by an anti-IL-4 monoclonal antibody in all types of brain tumor te
sted. IL2-PE4E and IL6-PE4E were not cytotoxic, nor was an IL4-PE4E mu
tant lacking ADP-ribosylating activity, indicating the IL4-PE4E-mediat
ed cytotoxicity of the brain tumor cells required both IL-4R binding a
nd enzymatic toxin activity. These data indicate that human neurologic
al cancer cells express IL-4R which are targets for the cytotoxic effe
cts of IL4-toxin. In addition, our data also suggest that IL4-PE4E sho
uld be studied further as a potential treatment for human neurological
cancers. (C) 1994 Wiley-Liss, Inc.